CAI Q4 2017 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$94M+21.7% YoY

Gross Profit

$49M52.5% margin

Operating Income

$34M35.7% margin

Net Income

$37M38.9% margin

EPS (Diluted)

$1.81

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

$50M

Free Cash Flow

-$174M

Stock-Based Comp.

$548,000

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.9B

Stockholders' Equity

$564M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$77M	+21.7%
Gross Profit	$49M	$33M	+49.8%
Operating Income	$34M	$17M	+93.8%
Net Income	$37M	$489,000	+7377.1%